Mark Bundesmann

Mark Bundesmann is a Senior Principal Scientist at Pfizer, where they have accumulated over 34 years of experience in pharmaceutical research and development. Having played a pivotal role in the early development of Parallel Medicinal Chemistry (PMC) in the mid-1990s, Mark significantly enhanced productivity in medicinal chemistry through the integration of automated purification technologies. Their expertise in flow chemistry has facilitated the scale-up of compounds from discovery through development stages. Mark leads cross-functional collaboration across multidisciplinary teams and is a co-author of numerous scientific publications, advocating for innovation and knowledge sharing in the field of drug discovery.